Clinical Trials in Salt Lake City

Showing 12621-12640 of 16,694 trials

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

NCT02080689

The influence of Decipher test on urologist and patient treatment plan choices immediately post RP and at the time of PSA rise or BCR

Prostate Cancer

GenomeDx Biosciences Corp286 participantsStarted May 2014

Anchorage, Alaska, United States • Los Angeles, California, United States • Aurora, Colorado, United States +16 more locations

COMPLETEDNA< 1 mile

Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM

NCT02428660

This randomized controlled trial will evaluate whether the use of pharmacogenetic testing through a Medication Therapy Management (MTM) program has a beneficial impact on drug therapy problems. More specifically, cytochrome DNA testing, which provides information with regards to participant specific metabolism of medications, will be used in the evaluation of participant medication regimens. The overall aim of the project is to evaluate if the addition of genetic CYP testing to a standardized MTM Program provides increased clinical value. To answer this question, the investigators will look at the drug therapy problems (DTPs) identified by the genetic test compared to those DTPs discovered without the test.

Cytochrome P450 CYP2D6 Enzyme DeficiencyPoor Metabolizer Due to Cytochrome P450 CYP2D6 VariantUltrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant+6 more

Genelex Corporation341 participantsStarted Feb 2015

Salt Lake City, Utah, United States

Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery

Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM

Find Trials by Condition in Salt Lake City

Naltrexone/Bupropion Cardiovascular Outcomes Study

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs

Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Factors Affecting PrEP Adherence

A Study Of Oral GW572016 In Advanced Or Metastatic Non-Small Cell Lung Cancer

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability

Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN

Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults

Safety and Efficacy of Somatropin in Children With Growth Hormone Deficiency

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

AFIX to Improve HPV Vaccination

Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients